GENERAL ATLANTIC, L.P. Q3 2025 Filing
Filed November 13, 2025
Portfolio Value
$3.3T
Holdings
16
Report Date
Q3 2025
Filing Type
13F-HR
All Holdings (16 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | DLODLOCAL | 46,656,695 | $666.3B | 20.00% | |
| 2 | XPXP, INC | 25,517,733 | $479.5B | 14.40% | |
| 3 | ALHCALIGNMENT HEALTHCARE | 24,287,227 | $423.8B | 12.72% | |
| 4 | CHYMCHIME | 19,208,760 | $387.4B | 11.63% | |
| 5 | ALKTALKAMI | 11,991,480 | $297.9B | 8.94% | |
| 6 | AKROAKERO THERAPEUTICS | 5,733,989 | $272.2B | 8.17% | |
| 7 | CNTACENTESSA PHARMACEUTICALS | 9,681,818 | $234.8B | 7.05% | |
| 8 | PHVSPHARVARIS | 8,031,252 | $200.4B | 6.02% | |
| 9 | RVMDREVOLUTION MEDICINES | 2,474,428 | $115.6B | 3.47% | |
| 10 | BULLWEBULL | 7,198,867 | $106.5B | 3.20% | |
| 11 | RPRXROYALTY PHARMA | 1,500,000 | $52.9B | 1.59% | |
| 12 | EWCZEUROPEAN WAX CENTER | 13,110,492 | $52.3B | 1.57% | |
| 13 | RSKDRISKIFIED | 5,324,998 | $24.9B | 0.75% | |
| 14 | ADAGADAGENE | 3,782,339 | $7.5B | 0.23% | |
| 15 | ALMSALUMIS | 1,297,530 | $5.2B | 0.16% | |
| 16 | GROVGROVE COLLABORATIVE | 2,474,859 | $3.7B | 0.11% |